T1	Participants 94 140	patients with advanced head and neck carcinoma
T2	Participants 354 597	patients with advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma. Patients with locally advanced or metastatic head and neck squamous cell carcinoma or nasopharyngeal carcinoma not suitable for operation or radiotherapy
T3	Participants 730 798	One hundred and thirty-six eligible patients were randomly assigned.
T4	Participants 1580 1654	advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma